Weighted Average Number of Shares Outstanding, Basic of Alzamend Neuro, Inc. from 30 Apr 2021 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Alzamend Neuro, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Apr 2021 to 31 Jan 2026.
  • Alzamend Neuro, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Jan 2026 was 3,804,741, a 522% increase year-over-year.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 450,799, a 508% increase from 2023.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 74,174, a 89% decline from 2022.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 650,126, a 99% decline from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Alzamend Neuro, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 3,804,741 +3,192,763 +522% 01 Nov 2025 31 Jan 2026 10-Q 11 Mar 2026 2026 Q3
Q3 2025 3,380,968 +2,988,557 +762% 01 Aug 2025 31 Oct 2025 10-Q 09 Dec 2025 2026 Q2
Q2 2025 2,106,036 +2,020,722 +2369% 01 May 2025 31 Jul 2025 10-Q 10 Sep 2025 2026 Q1
Q1 2025 450,799 +376,625 +508% 01 Feb 2025 30 Apr 2025 10-K 22 Jul 2025 2025 FY
Q4 2024 611,978 -93,454 -13% 01 Nov 2024 31 Jan 2025 10-Q 11 Mar 2026 2026 Q3
Q3 2024 392,411 -263,967 -40% 01 Aug 2024 31 Oct 2024 10-Q 09 Dec 2025 2026 Q2
Q2 2024 85,314 -570,953 -87% 01 May 2024 31 Jul 2024 10-Q 10 Sep 2025 2026 Q1
Q1 2024 74,174 -575,952 -89% 01 Feb 2024 30 Apr 2024 10-K 22 Jul 2025 2025 FY
Q4 2023 705,432 -5,849,646 -89% 01 Nov 2023 31 Jan 2024 10-Q 10 Mar 2025 2024 Q3
Q3 2023 656,378 -5,842,852 -90% 01 Aug 2023 31 Oct 2023 10-Q 11 Dec 2024 2024 Q2
Q2 2023 656,267 -96,825,523 -99% 01 May 2023 31 Jul 2023 10-Q 11 Sep 2024 2024 Q1
Q1 2023 650,126 01 Feb 2023 30 Apr 2023 10-K 30 Jul 2024 2024 FY
Q4 2022 6,555,078 01 Nov 2022 31 Jan 2023 10-Q 25 Mar 2024 2024 Q3
Q3 2022 6,499,230 01 Aug 2022 31 Oct 2022 10-Q 15 Dec 2023 2024 Q2
Q2 2022 97,481,790 01 May 2022 31 Jul 2022 10-Q 13 Sep 2023 2024 Q1

Alzamend Neuro, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 450,799 +376,625 +508% 01 May 2024 30 Apr 2025 10-K 22 Jul 2025 2025 FY
2023 74,174 -575,952 -89% 01 May 2023 30 Apr 2024 10-K 22 Jul 2025 2025 FY
2022 650,126 -88,445,148 -99% 01 May 2022 30 Apr 2023 10-K 30 Jul 2024 2024 FY
2021 89,095,274 +16,445,201 +23% 01 May 2021 30 Apr 2022 10-K 27 Jul 2023 2023 FY
2020 72,650,073 01 May 2020 30 Apr 2021 10-K 19 Jul 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.